Starting soon, millions of Medicare recipients will have the opportunity to obtain GLP-1 drugs at reduced costs for weight loss purposes.
This initiative aims to improve access to medications that may assist in weight management, potentially benefiting many individuals struggling with obesity.
Details on how this program will be implemented and the specific eligibility criteria are expected to be clarified in the coming months.